THE LYON SCORE: A NOVEL REFLUX SCORING SYSTEM BASED ON THE LYON CONSENSUS 2.0 THAT ASSOCIATES WITH TREATMENT OUTCOME FROM ANTI-REFLUX THERAPY

Gastrointestinal Cancer

Systemic Treatment Strategies and Outcomes of Patients With Synchronous Peritoneal Metastases of Gastric Origin: A Nationwide Population-Based Study

J Natl Compr Canc Netw

Guchelaar NAD, Noordman BJ, Welten MW, van Santen MT, de Neijs MJ, Koolen SLW, Verhoeven RHA, Oomen-de Hoop E, van der Sluis PC, Lagarde SM, van Laarhoven HWM, de Hingh IHJT, Creemers GJ, Mostert B, Wijnhoven BPL, Mathijssen RHJ

doi: 10.6004/jnccn.2024.7013

Inflammatory Bowel Disease

Association between inflammatory bowel disease, current therapies, and cardiovascular events: a review and meta-analysis of data from 2.2 million individuals

J Crohns Colitis

Thomas DR, Huangfu G, Yeaman F, Sukudom S, Lan NSR, Dwivedi G, Thin L

doi: 10.1093/ecco-jcc/jjaf078

Inflammatory Bowel Disease

Clinical outcomes after first-line anti-TNF treatment of patients with inflammatory bowel disease - a prospective multicenter cohort study

J Crohns Colitis

Zhao M, Larsen L, Dige A, Poulsen A, Lo B, Attauabi M, Dige Ovesen P, Wewer MD, Christiansen D, Hvas CL, Petersen AM, Bendtsen F, Seidelin J, Burisch J

doi: 10.1093/ecco-jcc/jjae192

Further Publications

A Prospective Comparison of Ustekinumab and Anti-TNF Therapy in the Treatment of Crohn's-like Disease of the Pouch

Am J Gastroenterol

Barnes EL, Raffals L, Qazi T, Deepak P, Chang S, Beniwal-Patel P, Higgins PD, Cross RK, Barr JI, Anderson C, Long MD, Herfarth HH, Dubinsky M, Kappelman MD, Kayal M

doi: 10.14309/ajg.0000000000003608

Inflammatory Bowel Disease

Metformin Is Associated With Improved Inflammatory Bowel Disease Outcomes in Patients With Type 2 Diabetes Mellitus: A Propensity-Matched Cohort Study

Inflamm Bowel Dis

Petrov JC, Desai AA, Kochhar GS, Crosby SK, Kinnucan JA, Picco MF, Hashash JG, Farraye FA

doi: 10.1093/ibd/izae147

Gastrointestinal Cancer

Immune-related Adverse Events are Associated with Improved Outcomes after Immune Checkpoint Inhibitor Treatment in Hepatocellular Carcinoma: A Systematic Review and Meta-analysis

Am J Gastroenterol

Hwang SY, Rezaee-Zavareh MS, Attia AM, Kaymen EA, Tran N, Abou-Alfa GK, Parikh ND, Singal AG, Yang JD

doi: 10.14309/ajg.0000000000003546

Hepatology

Renin-angiotensin-aldosterone system inhibitor use improves clinical outcomes in patients with metabolic dysfunction-associated steatotic liver diseases: Target trial emulation using real-world data

Hepatology

Ng WH, Yeo YH, Kim H, Seki E, Rees J, Ma KS, Moylan CA, Rodriquez LM, Abdelmalek M, Villanueva A, Noureddin M, Yang JD

doi: 10.1097/HEP.0000000000001333

Further Publications

Visual Endoscopic Retrograde Appendicitis Therapy versus Antibiotic Therapy for Treatment of Uncomplicated Acute Appendicitis

Am J Gastroenterol

Zhan K, Bai Y, Liu T, Su X, Yang Q, Liu Y, Zhou X, Zhang Y, Tang J, Jiang Z, Yang X, Liu W

doi: 10.14309/ajg.0000000000003118

Esophagus DiseasesGastroesophageal Reflux Disease (GERD)

VALIDATION OF ESOPHAGEAL GLOBAL SYMPTOM SEVERITY AS A PATIENT REPORTED OUTCOME FOR EVALUATION OF REFLUX SYMPTOMS

Am J Gastroenterol

Chan WW, Schroeder M, Richardson A, Shah N, Muftah M, Muftah S, Siboni S, Sozzi M, Wong MW, Chen CL, Gyawali CP, Milan Score Working Group

doi: 10.14309/ajg.0000000000003499

Related content

Systemic Treatment Strategies and Outcomes of Patients With Synchronous Peritoneal Metastases of Gastric Origin: A Nationwide Population-Based Study

Association between inflammatory bowel disease, current therapies, and cardiovascular events: a review and meta-analysis of data from 2.2 million individuals

Clinical outcomes after first-line anti-TNF treatment of patients with inflammatory bowel disease - a prospective multicenter cohort study

A Prospective Comparison of Ustekinumab and Anti-TNF Therapy in the Treatment of Crohn's-like Disease of the Pouch

Metformin Is Associated With Improved Inflammatory Bowel Disease Outcomes in Patients With Type 2 Diabetes Mellitus: A Propensity-Matched Cohort Study

Immune-related Adverse Events are Associated with Improved Outcomes after Immune Checkpoint Inhibitor Treatment in Hepatocellular Carcinoma: A Systematic Review and Meta-analysis

Renin-angiotensin-aldosterone system inhibitor use improves clinical outcomes in patients with metabolic dysfunction-associated steatotic liver diseases: Target trial emulation using real-world data

Visual Endoscopic Retrograde Appendicitis Therapy versus Antibiotic Therapy for Treatment of Uncomplicated Acute Appendicitis

VALIDATION OF ESOPHAGEAL GLOBAL SYMPTOM SEVERITY AS A PATIENT REPORTED OUTCOME FOR EVALUATION OF REFLUX SYMPTOMS